Literature DB >> 27284970

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis.

Hollie Burrell-Saward1, Theresa H Ward2.   

Abstract

Human African trypanosomiasis (HAT) is a multi-stage disease that manifests in two stages; an early blood stage and a late stage when the parasite invades the central nervous system (CNS). In vivo study of the late stage has been limited as traditional methodologies require the removal of the brain to determine the presence of the parasites. Bioluminescence imaging is a non-invasive, highly sensitive form of optical imaging that enables the visualization of a luciferase-transfected pathogen in real-time. By using a transfected trypanosome strain that has the ability to produce late stage disease in mice we are able to study the kinetics of a CNS infection in a single animal throughout the course of infection, as well as observe the movement and dissemination of a systemic infection. Here we describe a robust protocol to study CNS infections using a bioluminescence model of African trypanosomiasis, providing real time non-invasive observations which can be further analyzed with optional downstream approaches.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27284970      PMCID: PMC4927699          DOI: 10.3791/54032

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

1.  Bioluminescent monitoring of in vivo colonization and clearance dynamics by light-emitting bacteria.

Authors:  Siouxsie Wiles; Brian D Robertson; Gad Frankel; Angela Kerton
Journal:  Methods Mol Biol       Date:  2009

2.  The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapy.

Authors:  F W Jennings; D D Whitelaw; G M Urquhart
Journal:  Parasitology       Date:  1977-10       Impact factor: 3.234

3.  Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging.

Authors:  Niclas Hitziger; Isabel Dellacasa; Barbara Albiger; Antonio Barragan
Journal:  Cell Microbiol       Date:  2005-06       Impact factor: 3.715

Review 4.  Trypanosomiasis and the brain.

Authors:  Jean Rodgers
Journal:  Parasitology       Date:  2009-12-23       Impact factor: 3.234

5.  A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasis.

Authors:  Hollie Burrell-Saward; Jean Rodgers; Barbara Bradley; Simon L Croft; Theresa H Ward
Journal:  J Antimicrob Chemother       Date:  2014-10-08       Impact factor: 5.790

6.  Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration.

Authors:  Blandine Franke-Fayard; Chris J Janse; Margarida Cunha-Rodrigues; Jai Ramesar; Philippe Büscher; Ivo Que; Clemens Löwik; Peter J Voshol; Marion A M den Boer; Sjoerd G van Duinen; Maria Febbraio; Maria M Mota; Andrew P Waters
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-28       Impact factor: 11.205

Review 7.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

8.  Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.

Authors:  Jean Rodgers; Barbara Bradley; Peter G E Kennedy
Journal:  Parasitol Int       Date:  2007-06-29       Impact factor: 2.230

9.  Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection.

Authors:  Sushrut Kamerkar; Paul H Davis
Journal:  J Parasitol Res       Date:  2012-03-22

10.  Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection.

Authors:  Michael D Lewis; Amanda Fortes Francisco; Martin C Taylor; Hollie Burrell-Saward; Alex P McLatchie; Michael A Miles; John M Kelly
Journal:  Cell Microbiol       Date:  2014-05-01       Impact factor: 3.715

View more
  1 in total

1.  Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT).

Authors:  Dennis C Koester; Vanessa M Marx; Sarah Williams; Jan Jiricek; Maxime Dauphinais; Olivier René; Sarah L Miller; Lei Zhang; Debjani Patra; Yen-Liang Chen; Harry Cheung; Jonathan Gable; Suresh B Lakshminarayana; Colin Osborne; Jean-Rene Galarneau; Upendra Kulkarni; Wendy Richmond; Angela Bretz; Linda Xiao; Frantisek Supek; Christian Wiesmann; Srinivas Honnappa; Celine Be; Pascal Mäser; Marcel Kaiser; Ryan Ritchie; Michael P Barrett; Thierry T Diagana; Christopher Sarko; Srinivasa P S Rao
Journal:  J Med Chem       Date:  2022-08-22       Impact factor: 8.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.